What is the recommended treatment for patients taking VKA who experience ICH?
For patients with ICH taking VKA (Vitamin K Antagonists), rapid correction of the international normalized ratio (INR) is recommended. Treatment includes fresh frozen plasma (FFP) and vitamin K, as well as prothrombin complex concentrates (PCCs), the activated PCC FEIBA (factor VIII inhibitor bypassing activity), and recombinant activated factorVIIa (rFVIIa).